BEIJING: China's drug authority has granted emergency approval for the country's first specialized treatment against Covid-19, found in clinical trials to significantly reduce hospitalizations and deaths among high-risk patients.
The move comes as regulators around the world give the green light to treatments — particularly for high-risk groups — amid worries over the new Omicron variant.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.